14 employees
AVM Biotechnology is a clinical stage company.
2008
$2M
from 2 investors over 2 rounds
AVM Biotechnology raised $2M on June 14, 2022
Investors: National Institutes of Health
AVM Biotechnology raised $1.6M on April 5, 2022
Investors: NIDDK, NIH